Menora Mivtachim Holdings’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $645M | Buy |
|
|||||
2025
Q1 | $449M | Buy |
|
|||||
2024
Q4 | $626M | Sell |
|
|||||
2024
Q3 | $520M | Hold |
|
|||||
2024
Q2 | $469M | Buy |
|
|||||
2024
Q1 | $397M | Hold |
|
|||||
2023
Q4 | $294M | Hold |
|
|||||
2023
Q3 | $287M | Buy |
|
|||||
2023
Q2 | $200M | Sell |
|
|||||
2023
Q1 | $236M | Buy |
|
|||||
2022
Q4 | $212M | Sell |
|
|||||
2022
Q3 | $188M | Sell |
|
|||||
2022
Q2 | $175M | Hold |
|
|||||
2022
Q1 | $219M | Buy |
|
|||||
2021
Q4 | $184M | Buy |
|
|||||
2021
Q3 | $191M | Buy |
|
|||||
2021
Q2 | $162M | Hold |
|
|||||
2021
Q1 | $189M | Buy |
|
|||||
2020
Q4 | $146M | Buy |
|
|||||
2020
Q3 | $120M | Sell |
|
|||||
2020
Q2 | $221M | Buy |
|
|||||
2020
Q1 | $149M | Buy |
|
|||||
2019
Q4 | $82.4M | Buy |
|
|||||
2019
Q2 | – | Sell |
|
|||||
2019
Q1 | $30.8M | Sell |
|
|||||
2018
Q4 | $56.4M | Buy |
|
|||||
2018
Q3 | $1.26M | Hold |
|
|||||
2018
Q2 | $1.42M | Hold |
|
|||||
2018
Q1 | $999K | Sell |
|
|||||
2017
Q4 | $5M | Sell |
|
|||||
2017
Q3 | $48.6M | Buy |
|
|||||
2017
Q2 | $19.3M | Sell |
|
|||||
2017
Q1 | $19.9M | Sell |
|
|||||
2016
Q4 | $40.8M | Buy |
|
|||||
2016
Q3 | $2.56M | Hold |
|
|||||
2016
Q2 | $2.8M | Hold |
|
|||||
2016
Q1 | $2.98M | Hold |
|
|||||
2015
Q4 | $3.66M | Sell |
|
|||||
2015
Q3 | $22.8M | Hold |
|
|||||
2015
Q2 | $23.8M | Sell |
|
|||||
2015
Q1 | $50M | Sell |
|
|||||
2014
Q4 | $48.1M | Sell |
|
|||||
2014
Q3 | $47.6M | Sell |
|
|||||
2014
Q2 | $49.7M | Sell |
|
|||||
2014
Q1 | $51.2M | Sell |
|
|||||
2013
Q4 | $49.4M | Buy |
|
|||||
2013
Q3 | $33.7M | Sell |
|
|||||
2013
Q2 | $50.7M | Buy |
|